Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
13.63 USD | -2.85% | -10.62% | -47.94% |
Financials (USD)
Sales 2024 * | - | Sales 2025 * | 10M | Capitalization | 350M |
---|---|---|---|---|---|
Net income 2024 * | -71M | Net income 2025 * | -86M | EV / Sales 2024 * | - |
Net cash position 2024 * | 311M | Net cash position 2025 * | 430M | EV / Sales 2025 * | -8.01 x |
P/E ratio 2024 * |
-4.64
x | P/E ratio 2025 * |
-4.49
x | Employees | 44 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 77.39% |
Latest transcript on Tourmaline Bio, Inc.
1 day | -2.85% | ||
1 week | -10.62% | ||
Current month | -13.90% | ||
1 month | -12.06% | ||
3 months | -62.62% | ||
6 months | -23.81% | ||
Current year | -47.94% |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.01% | 0 M€ | 0.00% | - | |
0.00% | 17 M€ | +4.99% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-22 | 13.63 | -2.85% | 186,986 |
24-05-21 | 14.03 | -3.64% | 247,444 |
24-05-20 | 14.56 | -3.19% | 172,919 |
24-05-17 | 15.04 | +0.27% | 184,989 |
24-05-16 | 15 | -1.64% | 213,801 |
Delayed Quote Nasdaq, May 22, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-47.94% | 350M | |
+9.99% | 115B | |
+12.01% | 106B | |
-3.07% | 24.69B | |
-1.14% | 21.97B | |
-5.10% | 19.27B | |
-6.90% | 17.56B | |
-39.36% | 17.32B | |
+5.82% | 14.03B | |
+33.05% | 12.13B |
- Stock Market
- Equities
- TRML Stock